HL
TMO icon

HeadInvest LLC’s Thermo Fisher Scientific TMO Stock Holding History

HeadInvest LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
2,316
+238
+11% +$114K 0.22% 94
2026
Q1 		$1.02M Sell
2,078
-568
-21% -$308K 0.21% 92
2025
Q4 		$1.53M Buy
2,646
+1,007
+61% +$569K 0.3% 75
2025
Q3 		$795K Buy
1,639
+153
+10% +$71.2K 0.16% 111
2025
Q2 		$603K Sell
1,486
-70
-4% -$29.3K 0.13% 130
2025
Q1 		$774K Buy
1,556
+223
+17% +$121K 0.15% 121
2024
Q4 		$693K Buy
1,333
+248
+23% +$136K 0.13% 122
2024
Q3 		$671K Sell
1,085
-39
-3% -$23.1K 0.12% 123
2024
Q2 		$622K Sell
1,124
-7
-0.6% -$4.01K 0.12% 124
2024
Q1 		$657K Buy
1,131
+126
+13% +$70.7K 0.13% 119
2023
Q4 		$533K Buy
1,005
+334
+50% +$162K 0.11% 134
2023
Q3 		$333K Sell
671
-3
-0.4% -$1.6K 0.07% 170
2023
Q2 		$367K Sell
674
-61
-8% -$32.9K 0.08% 165
2023
Q1 		$424K Buy
735
+78
+12% +$44K 0.09% 153
2022
Q4 		$362K Sell
657
-21
-3% -$11.1K 0.08% 163
2022
Q3 		$344K Buy
678
+3
+0.4% +$1.68K 0.08% 159
2022
Q2 		$367K Hold
675
– – 0.08% 157
2022
Q1 		$399K Sell
675
-2
-0.3% -$1.15K 0.08% 166
2021
Q4 		$452K Buy
677
+3
+0.4% +$1.87K 0.08% 155
2021
Q3 		$385K Sell
674
-17
-2% -$9.33K 0.07% 164
2021
Q2 		$348K Buy
691
+6
+0.9% +$2.83K 0.07% 169
2021
Q1 		$312K Buy
685
+4
+0.6% +$1.91K 0.06% 177
2020
Q4 		$317K Buy
681
+159
+30% +$74.6K 0.07% 162
2020
Q3 		$230K Buy
+522
New +$216K 0.07% 167
2020
Q1 		– Sell
-649
Closed -$211K – 183
2019
Q4 		$211K Buy
+649
New +$197K 0.06% 188

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HeadInvest LLC's TMO Position: Q2 2026 in Review

HeadInvest LLC increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $114K and bringing the position to 2,316 shares worth $1.16M. The position accounts for 0.22% of the portfolio, ranked #94.

HeadInvest LLC first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.53M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • HeadInvest LLC held 2,316 shares of Thermo Fisher Scientific worth $1.16M as of Q2 2026.
  • HeadInvest LLC bought 238 Thermo Fisher Scientific shares in Q2 2026, an estimated $114K.
  • Thermo Fisher Scientific made up 0.22% of HeadInvest LLC's portfolio in Q2 2026, its #94 holding.
  • HeadInvest LLC first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
  • HeadInvest LLC's Thermo Fisher Scientific position peaked at $1.53M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HeadInvest LLC's 13F filing for Q2 2026, filed 14 Aug 2026.